Lymphoma Cancer Newsletter
Volume:V Issue:I
In this Issue:

Leukemia and Cancers of the Blood
      News You Can Use

Cyclophosphamide May Increase Cancer Risk Among Patients with Rheumatoid Arthritis

Being Overweight Associated with Increased Risk of Several Cancers

HemeScan™ Evaluates Prognosis in Chronic Lymphocytic Leukemia

Nexavar® May Be More Effective in AML with Specific Mutations

Fludara® Not Superior to Cytoxan® for Elderly with CLL

Genasense® Improves Long-term Survival in Recurrent Chronic Lymphocytic Leukemia

Campath® Possibly Superior to Chlorambucil for Initial Treatment of Chronic Lymphocytic Leukemia

Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma

Low-dose Steroids Improve Survival in Multiple Myeloma

Vidaza Improves Survival in High-risk Myelodysplastic Syndrome

Updates in the Management of Myelodysplastic Syndromes

Supportive Care and Hematologic Malignancies

Advances in the Management of Chronic Myeloid Leukemia

Prescribed Reading

Visit the Cancer Cancer Store to view the Prescribed Reading section.

Feature Articles

Join Our Community:
Connecting patients, survivors, and caregivers with essential support and information. Click here for more info.
Women and Cancer Magazine
advertisement
Search CancerConsultants
Newsletter Management:
To unsubscribe from this Cancer newsletter, send a blank email to optout@cancerconsultants.com.